LecTec Corporation and Endo Pharmaceuticals (ENDP) Settle Patent Dispute
11/12/2009 9:28:25 AM
More...
|
Endo Pharmaceuticals (ENDP) Reports Third Quarter 2009 Financial Results and Increases Full-Year Financial Guidance
10/29/2009 8:28:19 AM
More...
|
FDA Delays Endo Pharmaceuticals (ENDP)'s Testosterone Gel Approval
10/19/2009 12:19:24 PM
More...
|
Endo Pharmaceuticals (ENDP) to Announce Third Quarter 2009 Financial Results on October 29, 2009
10/8/2009 8:36:41 AM
More...
|
Endo Pharmaceuticals (ENDP) Says FDA Extends Review Date for Testosterone Treatment
9/3/2009 7:14:53 AM
More...
|
Endo Pharmaceuticals (ENDP) to Present at Thomas Weisel Partners Healthcare Conference 2009
9/1/2009 10:56:30 AM
More...
|
ProStrakan Group Signs Deal with Endo Pharmaceuticals (ENDP) for up to $210 Million
8/26/2009 7:13:08 AM
More...
|
Biotech 2009 to Feature Endo Pharmaceuticals (ENDP) President and CEO, David P. Holveck, as Dinner Keynote Speaker
8/18/2009 8:42:49 AM
More...
|
Endo Pharmaceuticals (ENDP) Announces Resignation of Chief Operating Officer
8/12/2009 6:48:50 AM
More...
|
Bioniche Life Sciences Inc. (BNC.TO) and Endo Pharmaceuticals (ENDP) Sign Licensing Agreement for Urocidin(TM); Endo Will Pay $20 Million Upfront and up to $110 Million
7/10/2009 6:30:11 AM
More...
|
|